Sort
30,917 grants matching “tumor microenvironment”
B7H1 Mediated Immunosuppression in Glioma
$291,821Orin Bloch · Northwestern University At Chicago · R01 · FY2017 · CA
BLOOD VESSEL TARGETING IN PROSTATE CANCER TREATMENT
$291,807University Of Texas Md Anderson Can Ctr · P50 · FY2002 · CA
THE BIOLOGY OF HUMAN PROSTATE CANCER METASTASIS
$291,807University Of Texas Md Anderson Can Ctr · P50 · FY2002 · CA
Cyr61-induced breast cancer: Clinical relevance and therapeutic development
$291,727Ruth Lupu · Mayo Clinic Rochester · R01 · FY2008 · CA
The oncogenic basis of Bmi-1 in neuroblastoma development
$291,722Han-Fei Ding · Augusta University · R01 · FY2008 · CA
P2: CTNNB1 Mutation and Wnt Pathway Activation Define Clinically Aggressive Endometrioid Endometrial Carcinoma
$291,693Russell R Broaddus · University Of Tx Md Anderson Can Ctr · P50 · FY2018 · CA
LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics
$291,684Ankur Singh · Cornell University · R33 · FY2019 · CA
Project 1- Micro-RNA-dependent signaling by the UPR
$291,676J. Alan Diehl · University Of Pennsylvania · P01 · FY2021 · CA
Project 1- Micro-RNA-dependent signaling by the UPR
$291,676J. Alan Diehl · University Of Pennsylvania · P01 · FY2020 · CA
Macrophage Dysfunction in Immunosenescence
$291,667University Of Louisville · R01 · FY2003 · AG
Countering immune resistance in the melanoma tumor microenvironment
$291,650Thomas F Gajewski · University Of Chicago · R01 · FY2009 · CA
Countering immune resistance in the melanoma tumor microenvironment
$291,650Thomas F Gajewski · University Of Chicago · R01 · FY2008 · CA
Countering immune resistance in the melanoma tumor microenvironment
$291,650Thomas F Gajewski · University Of Chicago · R01 · FY2010 · CA
Countering immune resistance in the melanoma tumor microenvironment
$291,650Thomas F Gajewski · University Of Chicago · R01 · FY2007 · CA
Notch as a New Therapeutic Target in Hematological Malignancies
$291,582Yulia Nefedova · Wistar Institute · R01 · FY2012 · CA
Gene-Engineered and Targeted Stem Cell Therapy for Myeloma
$291,538Selvarangan Ponnazhagan · University Of Alabama At Birmingham · R01 · FY2009 · CA
Molecular Determinants of Confined Migration
$291,527Cynthia A Reinhart-King · Vanderbilt University · R01 · FY2020 · GM
Pathway, Network and Spatiotemporal Integration of Cancer Genomics Data
$291,430Benjamin Raphael · Princeton University · U24 · FY2024 · CA
NF-kB Signaling in Osteoclastogenesis and Osteolytic Bone Metastasis
$291,367Cun-Yu Wang · University Of California Los Angeles · R01 · FY2013 · CA
Signaling in the ovarian cancer metastatic microenvironment
$291,367Jill Slack-Davis · University Of Virginia · R01 · FY2013 · CA
Immune cell interactions during tumor establishment.
$291,367Tomasz Zal · University Of Tx Md Anderson Can Ctr · R01 · FY2013 · CA
Antibody-CpG conjugates for the treatment of B cell lymphoma
$291,366John M Timmerman · University Of California Los Angeles · R01 · FY2013 · CA
Mechanisms of mucosal immune evasion in high grade cervical dysplasia
$291,362Cornelia L Trimble · Johns Hopkins University · R01 · FY2010 · CA
Core C: Animal Models
$291,352Stefan Niewiesk · Ohio State University · P01 · FY2014 · CA
Molecular Analysis of Signal Transduction in Cancer Development and Progression
$291,307Jun-Lin Guan · University Of Michigan At Ann Arbor · R01 · FY2010 · CA